Jason Wild

Jason Wild is the President & Chief Investment Officer of JW Asset Management, an SEC-registered investment adviser with more than $1.1 billion in assets under management. Starting his first fund in 1998 with under $100,000 in assets, Jason achieved early success by leveraging his background as a pharmacist finding undervalued, specialty pharmaceutical companies and focusing on long-term price appreciation.

After building a strong track record as a stock picker, Jason expanded his investment universe and applied his experience and extensive healthcare network to private equity opportunities. He has since established himself as a highly respected investor and sought-after partner for both public and private companies.

His firm’s 20+ year audited track record is a testament to consistently sourcing quality deal flow, identifying exceptional investment opportunities, and adding significant value as both a portfolio manager and trusted business partner. The firm’s largest fund has delivered 24%+ annualized returns, net of fees since inception. Jason is the Chairman of the Board for TerrAscend Corp. and serves on the board of Vitruvias Pharmaceuticals.